Ligation of lymphocyte function-associated antigen-1 on monocytes decreases very late antigen-4-mediated adhesion through a reactive oxygen species-dependent pathway

Blood

Volumn 104, Issue 13, 2004, Pages 4046-4053

  Chuang, Kuo Pin ^b   Huang, Ya Fang ^b   Hsu, Yi Ling ^b   Liu, Hsiao Sheng ^b   Chen, Hong Chen ^b   Shieh, Chi Chang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P47; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; XANTHINE OXIDASE;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION;

EID: 10244266318     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-05-1822     Document Type: Article

References (54)

1. Muller WA, Randolph GJ. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol. 1999;66:698-704.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
3. Greaves DR, Gordon S. Immunity, atherosclerosis and cardiovascular disease. Trends Immunol. 2001;22:180-181.
4. Steeber DA, Tedder TF. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol Res. 2001;22:299-317.
5. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
6. Chia MC. The role of adhesion molecules in atherosclerosis. Crit Rev Clin Lab Sci. 1998;35:573-602.
7. Ronald JA, Ionescu CV, Rogers KA, Sandig M. Differential regulation of transendothelial migration of THP-1 cells by ICAM-1/LFA-1 and VCAM-1/VLA-4. J Leukoc Biol. 2001;70:601-609.
8. Binnerts ME, van KY. How LFA-1 binds to different ligands. Immunol Today. 1999;20:240-245.
9. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 2002;3:151-158.
10. Chan BM, Elices MJ, Murphy E, Hemler ME. Adhesion to vascular cell adhesion molecule 1 and fibronectin: comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. J Biol Chem. 1992;267:8366-8370.
11. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
12. Hogg N, Henderson R, Leitinger B, et al. Mechanisms contributing to the activity of integrins on leukocytes. Immunol Rev. 2002;186:164-171.
13. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
14. Weber KS, Klickstein LB, Weber C. Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains. Mol Biol Cell. 1999;10:861-873.
15. Sedgwick JB, Quan SF, Calhoun WJ, Busse WW. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. J Allergy Clin Immunol. 1995;96:375-385.
16. Porter JC, Hogg N. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1 - and alpha5beta1-mediated function. J Cell Biol. 1997; 138:1437-1447.
17. Lin SJ, Wang JY, Klickstein LB, et al. Lack of age-associated LFA-1 up-regulation and impaired ICAM-1 binding in lymphocytes from patients with Down syndrome. Clin Exp Immunol. 2001;126: 54-63.
18. Chuang KP, Tsai WS, Wang YJ, Shieh CC. Superoxide activates very late antigen-4 on an eosinophil cell line and increases cellular binding to vascular cell adhesion molecule-1. Eur J Immunol. 2003;33:645-655.
19. Hoyal CR, Gutierrez A, Young BM, et al. Modulation of p47PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase. Proc Natl Acad Sci USA. 2003; 100:5130-5135.
20. Chen Q, Powell DW, Rane MJ, et al. Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils. J Immunol. 2003;170:5302-5308.
21. Dewas C, Fay M, Gougerot-Pocidalo MA, El Benna J. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils. J Immunol. 2000;165:5238-5241.
22. Bokoch GM. Regulation of the phagocyte respiratory burst by small GTP-binding proteins. Trends Cell Biol. 1995;5:109-113.
23. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60-66.
24. Lowell CA, Berten G. lntegrin signal transduction in myeloid leukocytes. J Leukoc Biol. 1999;65: 313-320.
25. Xiong JP, Stehle T, Goodman SL, Arnaout MA. New insights into the structural basis of integrin activation. Blood. 2003;102:1155-1159.
26. Chan JR, Hyduk SJ, Cybulsky MI. Alpha 4 beta 1 integrin/VCAM-1 interaction activates alpha L beta 2 integrin-mediated adhesion to ICAM-1 in human T cells. J Immunol. 2000;164:746-7153.
27. Rose DM, Liu S, Woodside DG, et al. Paxillin binding to the alpha 4 integrin subunit stimulates LFA-1 (integrin alpha L beta 2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinass-2, J Immunol. 2003;170:5912-5918.
28. Luscinskas FW, Kansas GS, Ding H, et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J Cell Biol. 1994;125:1417-1427.
29. Luscinskas FW, Ding H, Tan P et al. L- anc P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-alpha-activated vascular endothelium under flow in vitro. J Immunol. 1996;157:326-335.
30. Gerszten RE,Lim YC, Ding HT, et al. Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. Circ Res. 1998;82:871-878.
31. Huang AJ, Manning JE, Bandak TM, et al. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol. 1993;120:1371-1380.
32. Su WH, Chen HI, Huang JP, Jen CJ, Endothelial [Ca(2+)](i) signaling during transmigration of polymorphonuclear leukocytes. Blood, 2000;96: 3816-3822.
33. Babior BM. NADPH oxidase. Curr Opin Immunol. 2004;16:42-47.
34. Meischl C, Roos D. The molecular basis of chronic granulomatous disease. Semin Immunopathol. 1998;19:417-434.
35. Lin SJ, Huang YF, Chen JY, et al. Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease. Biochim Biophys Acta. 2002;1586: 275-286.
36. Meyer JW, Schmitt ME. A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett. 2000;472:1-4.
37. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
38. Walder CE, Green SP, Darbonne WC, et al. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke. 1997;28: 2252-2258.
39. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002; 347:1916-1923.
40. Sato TK, Overduin M, Emr SD. Location, location, location: membrane targeting directed by PX domains. Science. 2001;294:1881-1885.
41. Bokoch GM, Diebold BA. Current molecular models for NADPH oxidase regulation by Rac GT-Pase. Blood, 2002;100:2692-2696.
42. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
43. Sanchez-Martin L, Sanchez-Sanchez N, Gutierrez-Lopez MD, et al. Signaling through the leukocyte integrin LFA-1 in T cells induces a transient activation of Rac-1 that is regulated by Vav and P13K/AM-1. J Biol Chem. 2004;279:16194-16205.
44. Zhao T, Benard V, Bohi BP, Bokoch GM. The molecular basis for adhesion-mediated suppression of reactive oxygen species generation by human neutrophils.J Clin Invest. 2003;112:1732-1740.
45. Zhao X, Carnevale KA, Cathcart MK. Human monocytes use Rac1, not Rac2, in the NADPH oxidase complex. J Biol Chem. 2003;278:40788-40792.
46. Dib K, Melander F, Axelsson L, et al. Down-regulation of Rac activity during beta 2 integrin-mediated adhesion of human neutrophils. J Biol Chem. 2003;278:24181-24188.
47. Bonizzi G, Piette J, Merville MP, Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem Pharmacol. 2000;59:7-11.
48. Lambeth JD. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol. 2002;9:11-17.
49. Meng TC, Fukada T, Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell. 2002;9:387-399.
50. Khachigian LM, Collins T, Fries JW. N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo. Am J Pathol. 1997;151:1225-1229.
51. Moynagh PN, Williams DC, O'Neill LA. Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1: modulation by antioxidants. J Immunol. 1994; 153:2681-2690.
52. Chiarugi P, Pani G, Giannoni E, et al. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol. 2003;161:933-944.
53. Laragione T, Bonetto V, Casoni F, et al. Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomics. Proc Natl Acad Sci U S A. 2003;100:14737-14741.
54. Cayatte AJ, Rupin A, Oliver-Krasinskl J, et al. S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase. Arterioscler Thromb Vasc Biol. 2001;21:1577-1584.